Class II recall: Apollo Care, LLC: SEMAGLUTIDE 2.25MG (0.9 mg/mL), 2.5 mL Sterile Multi-Dose Vial, Rx Only, For Sub
FDA has classified a recall of Apollo Care, LLC's Semaglutide 2.25mg (0.9 mg/mL), 2.5 mL sterile multi-dose vials (NDC 71170-811-02, for subcutaneous injection only) as a Class II recall. The recall notice cites the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material in the product.
Most relevant for: pediatric patients prescribed semaglutide injections who may have received affected vials from Apollo Care, LLC
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More pediatrics updates
- Broad-spectrum antibiotics show no benefit for CAP in complex childrenOct 7, 2026
- AAP Policy Statement Addresses Infection Risks of Raw MilkOct 5, 2026
- Commercial pediatric sepsis alert shows low sensitivity in ED studyOct 5, 2026
- Multi-condition care pathways boost guideline adherence in general hospitalsOct 1, 2026
- AAP revises pediatric UTI diagnostic definition for 2026 guidelineOct 1, 2026